Bank of New York Mellon Corp - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 163 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$602,707
-17.8%
558,062
-1.8%
0.00%
Q2 2023$733,029
-0.3%
568,239
+2.0%
0.00%
Q1 2023$735,030
-13.2%
556,841
-1.4%
0.00%
Q4 2022$846,968
+26.2%
564,645
-0.7%
0.00%
Q3 2022$671,000
+13.3%
568,712
+8.6%
0.00%
Q2 2022$592,000
-64.3%
523,609
-5.4%
0.00%
Q1 2022$1,656,000
+13.2%
553,621
+0.3%
0.00%
Q4 2021$1,463,000
-25.6%
552,174
+1.9%
0.00%
Q3 2021$1,967,000
-11.5%
542,015
+5.9%
0.00%
Q2 2021$2,222,000
+4.9%
511,935
-17.3%
0.00%
Q1 2021$2,118,000
-9.6%
619,161
-7.6%
0.00%
-100.0%
Q4 2020$2,344,000
+44.9%
669,956
-0.6%
0.00%
Q3 2020$1,618,000
+29.0%
674,131
-1.7%
0.00%
Q2 2020$1,254,000
+16.7%
685,481
-0.5%
0.00%
Q1 2020$1,075,000
-27.1%
688,9330.0%0.00%
Q4 2019$1,474,000
+16.4%
688,933
+1.8%
0.00%
Q3 2019$1,266,000
-32.1%
677,012
-5.3%
0.00%
-100.0%
Q2 2019$1,865,000
+1.4%
714,537
-0.2%
0.00%0.0%
Q1 2019$1,840,000
+11.8%
716,091
+0.1%
0.00%0.0%
Q4 2018$1,646,000
-25.8%
715,482
+3.5%
0.00%0.0%
Q3 2018$2,218,000
+5.0%
691,046
-7.4%
0.00%0.0%
Q2 2018$2,112,000
-21.0%
746,322
-1.2%
0.00%0.0%
Q1 2018$2,674,000
-8.0%
755,460
+0.9%
0.00%0.0%
Q4 2017$2,905,000
+106.9%
748,963
+35.4%
0.00%
Q3 2017$1,404,000
-7.4%
553,172
-0.4%
0.00%
Q2 2017$1,516,000
-20.8%
555,517
-4.0%
0.00%
-100.0%
Q1 2017$1,915,000
+79.8%
578,414
+29.3%
0.00%
Q4 2016$1,065,000
-32.4%
447,252
+4.2%
0.00%
Q3 2016$1,575,000
+61.7%
429,114
-1.8%
0.00%
Q2 2016$974,000
+4.3%
436,771
-2.8%
0.00%
Q1 2016$934,000
-27.7%
449,285
+5.5%
0.00%
Q4 2015$1,291,000
+22.1%
425,945
-0.4%
0.00%
Q3 2015$1,057,000
-35.4%
427,822
-16.1%
0.00%
Q2 2015$1,636,000
-8.3%
509,699
+1.9%
0.00%
Q1 2015$1,785,000
+46.1%
500,027
-7.1%
0.00%
Q4 2014$1,222,000
+20.2%
538,123
+2.6%
0.00%
Q3 2014$1,017,000
-70.5%
524,399
-44.8%
0.00%
Q2 2014$3,450,000
+81.4%
950,540
+93.9%
0.00%
-100.0%
Q1 2014$1,902,000
+49.4%
490,298
+9.8%
0.00%
Q4 2013$1,273,000
-59.5%
446,708
-49.1%
0.00%
Q3 2013$3,142,000
+107.7%
877,664
+93.7%
0.00%
Q2 2013$1,513,000453,1000.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Sio Capital Management, LLC 1,020,719$3,746,0002.58%
Boxer Capital, LLC 1,351,137$4,959,0002.22%
Palo Alto Investors LP 5,186,088$19,033,0001.11%
DAFNA Capital Management LLC 340,000$1,248,0000.87%
SENZAR ASSET MANAGEMENT, LLC 907,203$3,329,435,0000.86%
Rhenman & Partners Asset Management AB 1,400,000$5,138,000,0000.82%
NEA Management Company, LLC 3,243,150$11,902,0000.53%
Cormorant Asset Management, LP 1,155,600$4,241,0000.47%
Ghost Tree Capital, LLC 700,000$2,569,0000.42%
Rock Springs Capital Management LP 1,810,000$6,643,0000.42%
View complete list of RIGEL PHARMACEUTICALS INC shareholders